0001740279 2026-08-06 2026-08-06 0001740279 1 2026-08-06 2026-08-06 0001740279 2 2026-08-06 2026-08-06 iso4217:USD pure shares S-8 S-8 EX-FILING FEES 0001740279 IN8BIO, INC. N/A false false S-8 IN8BIO, INC. Equity Common Stock, par value $0.0001 per share true 496000 1.01 500960.00 0.0001381 69.18 Equity Common Stock, par value $0.0001 per share true 4000 0.96 3840.00 0.0001381 0.53 504800.00 69.71 0.00 69.71 Represents shares of common stock reserved for issuance under the Registrant's 2026 Inducement Plan (the "2026 Plan"). Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement shall also cover any additional shares of common stock that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction with respect to the shares of common stock being registered pursuant to this registration statement. The proposed maximum offering price per share is estimated in accordance with Rules 457(c) and 457(h) promulgated under the Securities Act solely for the purpose of calculating the registration fee and is based upon a price per share of $1.01, which is the average of the high and low prices per share of common stock on August 3, 2026, as reported on The Nasdaq Capital Market. Represents shares of common stock issuable upon the exercise of an outstanding stock option award granted pursuant to the 2026 Plan. Pursuant to Rule 416(a) promulgated under the Securities Act, this registration statement shall also cover any additional shares of common stock that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction with respect to the shares of common stock being registered pursuant to this registration statement. The proposed maximum offering price per share is estimated in accordance with Rule 457(h) promulgated under the Securities Act solely for the purpose of calculating the registration fee and is based upon the exercise price for such shares.